Guest guest Posted August 16, 2004 Report Share Posted August 16, 2004 Whooping Cough Vaccine http://www.healthcentral.com/PrintFormat/PrintFullText2.cfm?id=8009296 Ivanhoe Broadcast News NASHVILLE, Tenn. (Ivanhoe Broadcast News) -- Pertussis or whooping cough has been called the hundred-day cough because it can last that long. After a vaccine was developed in the 1940s, the number of cases dropped, but now it's rising with as many as 8,000 cases a year. In infants, it can be fatal. Here's what's being done to protect more babies from the disease. Four-month-old Hamp visits the doctor today, but his appointment is special. Hamp is part of a clinical trial that's changing his vaccine schedule. Normally, a baby starts their series of three whooping cough vaccines at two months. Hamp got his first dose when he was born. " We are glad to be in this study, " says Hamp's mother, Anne Marie. " We are glad to be helping and glad that we can be part of something that might help children, especially later down the line. " Pediatrician Natasha Halasa, M.D., says whooping cough is highly contagious. If infants catch it from an adult, it can turn deadly. That's why the earlier they start to be protected, the better. " Kids could actually mount an immune response and get their second vaccine by two months of age, protecting them earlier, instead of waiting until four months, where they get the second shot, " Dr. Halasa, of Vanderbilt Children's Hospital in Nashville, Tenn., tells Ivanhoe. It happened to 9-month-old Blayne Sands. When he was 5 weeks old, he got whooping cough and stopped breathing for 21 seconds. Blayne's mom, Starla, says, " You just cannot explain the fear, the emotion you go through, the helplessness. " She says, while it's hard to talk about what happened to her son, she feels it's important to tell parents to take this disease seriously. " If it is an adult-sounding cough, and they are gasping for air, they need to be checked out, " she says. Like many babies, Hamp is not happy about his vaccines. What he doesn't realize is that the study he's involved in could save babies in the future from a dangerous disease. There are two other options being considered to decrease the number of whooping cough cases. Researchers are looking at vaccinating women while they are pregnant or to add another vaccination during the adolescent years. This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/ .. If you would like more information, please contact: > Carole Bartoo > Public Relations Manager > Vanderbilt Children's Hospital > 2200 Children's Way, Suite 2515 > Nashville, TN 37232 > (615) 322-4747 > http://www.vanderbilt.edu > > Last Updated: August 16, 2004 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 16, 2004 Report Share Posted August 16, 2004 omg, the earlier they give it, the more likely to say that any neuro/health problems were congenital. Then htey are really out of the liability because parents will never know what " normal " was to be for their child. the sheer fact that she's happy to allow her son to be a guinea pig is enough to make me want to vomit (as does much of the vaccine crap) in IL Whooping Cough Vaccine > Whooping Cough Vaccine > > http://www.healthcentral.com/PrintFormat/PrintFullText2.cfm?id=8009296 > > > Ivanhoe Broadcast News > > > > NASHVILLE, Tenn. (Ivanhoe Broadcast News) -- Pertussis or whooping cough has > been called the hundred-day cough because it can last that long. After a > vaccine was developed in the 1940s, the number of cases dropped, but now it's > rising with as many as 8,000 cases a year. In infants, it can be fatal. Here's > what's being done to protect more babies from the disease. > > Four-month-old Hamp visits the doctor today, but his appointment is > special. Hamp is part of a clinical trial that's changing his vaccine schedule. > Normally, a baby starts their series of three whooping cough vaccines at two > months. Hamp got his first dose when he was born. > > " We are glad to be in this study, " says Hamp's mother, Anne Marie. " We are > glad to be helping and glad that we can be part of something that might help > children, especially later down the line. " > > Pediatrician Natasha Halasa, M.D., says whooping cough is highly contagious. > If infants catch it from an adult, it can turn deadly. That's why the earlier > they start to be protected, the better. > > " Kids could actually mount an immune response and get their second vaccine by > two months of age, protecting them earlier, instead of waiting until four > months, where they get the second shot, " Dr. Halasa, of Vanderbilt Children's > Hospital in Nashville, Tenn., tells Ivanhoe. > > It happened to 9-month-old Blayne Sands. When he was 5 weeks old, he got > whooping cough and stopped breathing for 21 seconds. > > Blayne's mom, Starla, says, " You just cannot explain the fear, the emotion > you go through, the helplessness. " She says, while it's hard to talk about what > happened to her son, she feels it's important to tell parents to take this > disease seriously. " If it is an adult-sounding cough, and they are gasping for > air, they need to be checked out, " she says. > > Like many babies, Hamp is not happy about his vaccines. What he doesn't > realize is that the study he's involved in could save babies in the future from a > dangerous disease. > > There are two other options being considered to decrease the number of > whooping cough cases. Researchers are looking at vaccinating women while they are > pregnant or to add another vaccination during the adolescent years. > > This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail > every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/ > . > > If you would like more information, please contact: > > > > Carole Bartoo > > Public Relations Manager > > Vanderbilt Children's Hospital > > 2200 Children's Way, Suite 2515 > > Nashville, TN 37232 > > (615) 322-4747 > > http://www.vanderbilt.edu > > > > > > > > Last Updated: August 16, 2004 > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 17, 2004 Report Share Posted August 17, 2004 Hi all, I sent this article to Dr. Sherri, and she asked me to look into the study more. Thought you may be interested. http://www.mc.vanderbilt.edu/reporter/?ID=3023 Deadly pertussis focus of VCH study “I think several strategies would be good to try,†said Halasa. “Pregnant mothers given the vaccine may pass some protection on to babies, adolescent boosters would reduce the chances of adolescents or adults giving it to babies, but we’re about to study how effective it would be to give a baby’s first pertussis vaccination earlier in life… at birth.†Right now Halasa is looking to enroll 50 women who are preparing to deliver full term babies or healthy infants between the ages 2-14 days who have not yet received their Hepatitis B vaccination. In this pilot study, 25 newborns will get the normal Hepatitis B vaccine at birth, while the other 25 will get a diphtheria, tetanus and acellular pertussis (DTaP) vaccination along with their Hepatitis B vaccine, that’s two months before the normal schedule to begin vaccination for pertussis. The main purpose of this study is to determine if it is safe to administer an additional dose of the pertussis vaccine in the first days of life and also to see if babies can mount an adequate immune response. If it is successful, Halasa hopes an eventual change in the immunization schedule might save babies’ lives. For more information on the study email NPVstudy@... or Call Alice O’Shea at 343-8518. http://www.vanderbiltchildrens.com/uploads/documents/fall-winter02-03.pdf “We’re working to design a very careful pilot trial to look at pertussis immunization at birth,†says , “to see if we can speed up the protection we can afford to children.†Another area of concern for the vaccine research group is how well vaccines protect children in the community from disease. For the past three years or so, the CDC has funded and Dr. Marie , professor of Preventive Medicine, to conduct surveillance studies looking at the incidence of vaccine-preventable diseases, checking especially to see whether vaccine protection is long-lived. The CDC has also funded Vanderbilt to look at adverse effects associated with vaccines. These studies are possible through liaisons with the State Department of Health and through collaborations with community pediatricians who are members of the Cumberland Pediatric Foundation, a network of 300 primary care and academic pediatricians in the Middle Tennessee area. “Vanderbilt has had a major role in evaluating many vaccines for the past two decades, a role that has been enhanced by recent CDC and NIH funding “So this is an exceedingly important place to look at vaccines,†she says, “to test the vaccines from the beginning, to make sure they are safe and effective, to participate in vaccine licensing and policy decisions at the FDA and CDC, and then to follow their safety and their effectiveness (over the long term).†says the work done at Vanderbilt in disease prevention in children is remarkable and a strength that should be applauded. Dr. Natasha B. Halasa same Dr. in the study http://www.journals.uchicago.edu/cgi-bin/embpcgi.pl/cgi-bin/res-page.epl?objid=4\ 21033 Prevalence of Pertussis Antibodies in Maternal Delivery, Cord, and Infant Serum Author(s) C. Healy, Flor M. Munoz, Marcia A. Rench, Natasha B. Halasa, M. , and Carol J. Baker Identifiers The Journal of Infectious Diseases, volume 190 (2004), page 335 DOI: 10.1086/421033 PubMed ID: 15216470 Availability This site:  PS  | HTML  | PDF (129.0k)  [subscription required] Copyright © 2004, the Infectious Diseases Society of America. Abstract Background.     Passively acquired maternal antibodies protect infants from many pathogens. With increasing reports of infant pertussis, we evaluated pertussis antibodies in maternal-infant paired sera from 1999 2000.Methods.     Antibodies to pertussis toxin (PT), filamentous hemagglutinin (FHA), and fimbrial proteins (FIM) were measured by validated IgG-specific enzyme-linked immunosorbant assay (ELISA) in 64 maternalumbilical cord serum pairs and in 61 of 64 infant sera. Geometric mean concentrations (GMCs) of pertussis antibodies and cord : maternal GMC ratios were calculated.Results.     Mean maternal age and gestation were 29.7 years (range, 1942) and 39.3 weeks (range, 35.6 40.9), and 81% of mothers were white. GMCs of maternal antibodies at delivery (ELISA units/mL) were 2.4 for PT, 6.9 for FHA, and 13 for FIM. Cord GMCs were 169%, 178%, and 157% of maternal delivery values for PT, FHA, and FIM, respectively, demonstrating active placental transfer (P<.001). Pertussis-specific IgG values for each antigen decayed to below the threshold of detection by age 2 months.Conclusions.     Despite efficient placental transfer, low maternal pertussis antibody levels and their rapid decay in infant sera leave infants with little humoral protection against pertussis. These data support the rationale for maternal or neonatal immunization, with acellular pertussis vaccines, to prevent life-threatening pertussis in early infancy. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 17, 2004 Report Share Posted August 17, 2004 At Birth???? Those poor poor babies! -- Aimee, Mom to Marah-Jade Born 09/17/03 vaccine free since 12/03 " Half of the modern drugs could well be thrown out of the window, except that the birds might eat them. Dr. Henry Fischer " -------------- Original message -------------- Whooping Cough Vaccine http://www.healthcentral.com/PrintFormat/PrintFullText2.cfm?id=8009296 Ivanhoe Broadcast News NASHVILLE, Tenn. (Ivanhoe Broadcast News) -- Pertussis or whooping cough has been called the hundred-day cough because it can last that long. After a vaccine was developed in the 1940s, the number of cases dropped, but now it's rising with as many as 8,000 cases a year. In infants, it can be fatal. Here's what's being done to protect more babies from the disease. Four-month-old Hamp visits the doctor today, but his appointment is special. Hamp is part of a clinical trial that's changing his vaccine schedule. Normally, a baby starts their series of three whooping cough vaccines at two months. Hamp got his first dose when he was born. " We are glad to be in this study, " says Hamp's mother, Anne Marie. " We are glad to be helping and glad that we can be part of something that might help children, especially later down the line. " Pediatrician Natasha Halasa, M.D., says whooping cough is highly contagious. If infants catch it from an adult, it can turn deadly. That's why the earlier they start to be protected, the better. " Kids could actually mount an immune response and get their second vaccine by two months of age, protecting them earlier, instead of waiting until four months, where they get the second shot, " Dr. Halasa, of Vanderbilt Children's Hospital in Nashville, Tenn., tells Ivanhoe. It happened to 9-month-old Blayne Sands. When he was 5 weeks old, he got whooping cough and stopped breathing for 21 seconds. Blayne's mom, Starla, says, " You just cannot explain the fear, the emotion you go through, the helplessness. " She says, while it's hard to talk about what happened to her son, she feels it's important to tell parents to take this disease seriously. " If it is an adult-sounding cough, and they are gasping for air, they need to be checked out, " she says. Like many babies, Hamp is not happy about his vaccines. What he doesn't realize is that the study he's involved in could save babies in the future from a dangerous disease. There are two other options being considered to decrease the number of whooping cough cases. Researchers are looking at vaccinating women while they are pregnant or to add another vaccination during the adolescent years. This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/ .. If you would like more information, please contact: > Carole Bartoo > Public Relations Manager > Vanderbilt Children's Hospital > 2200 Children's Way, Suite 2515 > Nashville, TN 37232 > (615) 322-4747 > http://www.vanderbilt.edu > > Last Updated: August 16, 2004 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 17, 2004 Report Share Posted August 17, 2004 This woman should be charged with child abuse. She handed over her new baby to be a guinea pig. hhmmm I wonder how she would feel if her baby died from this. I can hear her interview comments now " I am so proud that my baby could give his life to test this theory so that other babies might not die from this terrible disease " lets all contact this carole bartoo and tell her what a dope she is Whooping Cough Vaccine http://www.healthcentral.com/PrintFormat/PrintFullText2.cfm?id=8009296 Four-month-old Hamp visits the doctor today, but his appointment is special. Hamp is part of a clinical trial that's changing his vaccine schedule. Normally, a baby starts their series of three whooping cough vaccines at two months. Hamp got his first dose when he was born. " We are glad to be in this study, " says Hamp's mother, Anne Marie. " We are glad to be helping and glad that we can be part of something that might help children, especially later down the line. " If you would like more information, please contact: > Carole Bartoo > Public Relations Manager > Vanderbilt Children's Hospital > 2200 Children's Way, Suite 2515 > Nashville, TN 37232 > (615) 322-4747 > http://www.vanderbilt.edu > > Last Updated: August 16, 2004 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.